Cargando…
Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs
Seventeen dogs were treated with L-ornithin-L-aspartate (LOLA; experimental group). Three dogs were treated with lactulose recognized therapy (control group). Following LOLA administration, 15 dogs experienced a significant decrease in ammonia level (p < 0.05) and showed clinical signs of improve...
Autores principales: | Ahn, Jin-Ok, Li, Qiang, Lee, Young-Heun, Han, Sei-Myoung, Hwang, Cheol-Yong, Youn, Hwa-Young, Chung, Jin-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037314/ https://www.ncbi.nlm.nih.gov/pubmed/26726023 http://dx.doi.org/10.4142/jvs.2016.17.3.431 |
Ejemplares similares
-
Pharmacokinetic and Pharmacodynamic Properties of l-Ornithine l-Aspartate (LOLA) in Hepatic Encephalopathy
por: Kircheis, Gerald, et al.
Publicado: (2019) -
Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers
por: Lee, Jeong-Seon, et al.
Publicado: (2021) -
Effect of Rifaximin, Probiotics, and l-Ornithine l-Aspartate on Minimal Hepatic Encephalopathy: A Randomized Controlled Trial
por: Sharma, Kapil, et al.
Publicado: (2014) -
l-Ornithine l-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses
por: Butterworth, Roger F., et al.
Publicado: (2019) -
Hyperammonemic Coma in an Adult due to Ornithine Transcarbamylase Deficiency
por: Roberts, Daniel L., et al.
Publicado: (2013)